<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS202416</article-id><article-id pub-id-type="doi">10.1101/2024.12.20.629673</article-id><article-id pub-id-type="archive">PPR960436</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>The last resort antibiotic daptomycin exhibits two independent antibacterial mechanisms of action</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Buttress</surname><given-names>Jessica A.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Schafer</surname><given-names>Ann-Britt</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Koh</surname><given-names>Alan</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A4">4</xref><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Wheatley</surname><given-names>Jessica</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Mickiewicz</surname><given-names>Katarzyna</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wenzel</surname><given-names>Michaela</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Strahl</surname><given-names>Henrik</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Centre for Bacterial Cell Biology, Biosciences Institute, Faculty of Medical Sciences, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/01kj2bm70</institution-id><institution>Newcastle University</institution></institution-wrap>, <city>Newcastle upon Tyne</city>, <country country="GB">UK</country></aff><aff id="A2"><label>2</label>Division of Chemical Biology, Department of Life Sciences, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/040wg7k59</institution-id><institution>Chalmers University of Technology</institution></institution-wrap>, <city>Gothenburg</city>, <country country="SE">Sweden</country></aff><aff id="A3"><label>3</label>Center for Antibiotic Resistance Research in Gothenburg (CARe), Gothenburg, Sweden</aff><aff id="A4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05p1n6x86</institution-id><institution>MRC London Institute of Medical Sciences</institution></institution-wrap>, <city>London</city>, <country country="GB">UK</country></aff><aff id="A5"><label>5</label>Institute of Clinical Sciences, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/041kmwe10</institution-id><institution>Imperial College</institution></institution-wrap>, <city>London</city>, <country country="GB">UK</country></aff><author-notes><corresp id="CR1">
<label>*</label>Corresponding author Henrik Strahl (<email>h.strahl@ncl.ac.uk</email>)</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>17</day><month>01</month><year>2025</year></pub-date><pub-date pub-type="preprint"><day>21</day><month>12</month><year>2024</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">Daptomycin is a lipopeptide antibiotic, commonly used as last resort treatment against multidrug resistant Gram-positive pathogens. Despite its clinical success, the mechanism through which daptomycin exerts its antibacterial properties has remained controversial. Much of the debate is focused around daptomycin’s ability to depolarise the cytoplasmic membrane, potential formation of large membrane pores, and its more recently discovered capability to inhibit cell wall synthesis and disturb membrane lipid domain organisation through interactions with cell wall precursor lipids. Here we show that, rather than representing different facets of a single underlying activity, daptomycin exhibits two independent antibacterial mechanisms of action: (i) targeting of cell wall precursor lipids that leads to cell wall synthesis inhibition and (ii) membrane depolarisation that does not rely on interactions with cell wall precursor lipids. This dual mechanism of action provides an explanation for the frequently disagreeing findings obtained through <italic>in vivo</italic> and <italic>in vitro</italic> studies and explains why resistance development towards daptomycin is slow and multifactorial. In a broader context, this demonstrates that dual mechanism antibiotics can be clinically successful and exhibit favourable characteristics in terms of real-world, clinically relevant resistance development.</p></abstract><kwd-group><kwd>Daptomycin</kwd><kwd>antibacterial mechanism of action</kwd><kwd>membrane depolarisation</kwd><kwd>lipid II</kwd><kwd>cell wall synthesis</kwd><kwd><italic>Bacillus subtilis</italic></kwd><kwd><italic>Staphylococcus aureus</italic></kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">Daptomycin is a lipopeptide antibiotic that displays excellent activity against Gram-positive pathogens and is often implemented as a last resort agent to combat multidrug-resistant bacterial infections<sup><xref ref-type="bibr" rid="R1">1</xref></sup>. Despite its clinical importance, the precise mechanism of action of daptomycin is still heavily debated. In particular, much controversy is centred on whether daptomycin forms large pores in the cytoplasmic membrane of target cells and how it inhibits cell wall synthesis; with many discrepancies transpiring from differences between <italic>in vivo</italic> and <italic>in vitro</italic> studies<sup><xref ref-type="bibr" rid="R2">2</xref>–<xref ref-type="bibr" rid="R4">4</xref></sup>.</p><p id="P3">Daptomycin, originally isolated as a secondary metabolite produced by the Gram-positive soil bacterium <italic>Streptomyces roseosporus</italic><sup><xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R6">6</xref></sup>, is a lipodepsipeptide consisting of a 10-membered cyclic lactone core and three exocyclic amino acids linked to a decanoyl fatty acid tail<sup><xref ref-type="bibr" rid="R7">7</xref>,<xref ref-type="bibr" rid="R8">8</xref></sup>. Unlike most antibacterial lipopeptides, daptomycin is negatively charged, and its antimicrobial activity depends on bound Ca<sup>2+</sup> ions, which reduce the negative charge of the peptide and stimulate its oligomerisation<sup><xref ref-type="bibr" rid="R9">9</xref>–<xref ref-type="bibr" rid="R12">12</xref></sup>. The resulting daptomycin-calcium complex therefore has an increased affinity for anionic bacterial phospholipids such as phosphatidylglycerol (PG)<sup><xref ref-type="bibr" rid="R13">13</xref></sup>. PG is particularly abundant in the cell membranes of Gram-positive bacteria<sup><xref ref-type="bibr" rid="R14">14</xref></sup>, thereby promoting daptomycin’s selectivity for bacterial over mammalian membranes<sup><xref ref-type="bibr" rid="R15">15</xref></sup>. Gram-negative bacteria are generally resistant towards daptomycin due to its inability to traverse the outer membrane barrier<sup><xref ref-type="bibr" rid="R16">16</xref></sup>, although their different phospholipid composition also appears to play a role<sup><xref ref-type="bibr" rid="R17">17</xref></sup>.</p><p id="P4">Studies focusing on daptomycin’s mechanism of action (direct drug-target interactions leading to inhibition) and mode of action (cellular consequences of target inhibition) have provided controversial results for several decades, with the earliest research arguing that daptomycin inhibits peptidoglycan synthesis<sup><xref ref-type="bibr" rid="R7">7</xref>,<xref ref-type="bibr" rid="R18">18</xref></sup>. The drug approval by FDA, in contrast, cites membrane depolarisation as the primary mechanism of action<sup><xref ref-type="bibr" rid="R19">19</xref></sup>. Previous work by ourselves and collaborators demonstrated, using fluorescent lipid probes and fluorescent protein-fusions, that daptomycin preferentially inserts into fluid membrane microdomains in <italic>Bacillus subtilis</italic> and triggers their clustering<sup><xref ref-type="bibr" rid="R20">20</xref></sup>. This change in membrane organisation impairs the attachment of several peripheral membrane proteins, most prominently the lipid II synthase MurG, the membrane association of which is essential for peptidoglycan synthesis<sup><xref ref-type="bibr" rid="R21">21</xref></sup>. More recently, daptomycin was demonstrated to inhibit the cell wall synthetic machinery even more directly by forming a tripartite complex with PG and undecaprenyl-coupled cell wall precursors including lipid II<sup><xref ref-type="bibr" rid="R22">22</xref>,<xref ref-type="bibr" rid="R23">23</xref></sup>. The associated steric hindrance likely explains the observed inhibition of cell wall synthesis<sup><xref ref-type="bibr" rid="R7">7</xref>,<xref ref-type="bibr" rid="R18">18</xref></sup>, as well as dissociation of MurG from the membrane surface<sup><xref ref-type="bibr" rid="R20">20</xref></sup>.. The question remains, however, why daptomycin remains active against both <italic>Enterococcus faecium</italic> protoplasts and cell wall-less <italic>B. subtilis</italic> L-forms, which both lack a cell wall and therefore are unlikely to be affected by the cell wall-targeting activity of this antibiotic<sup><xref ref-type="bibr" rid="R24">24</xref>,<xref ref-type="bibr" rid="R25">25</xref></sup>. In contrast to a mechanism based on inhibition of cell wall synthesis, several <italic>in vitro</italic> studies using model membrane systems have shown that daptomycin forms cation-selective, relatively small membrane pores of less than 10 Å diameter<sup><xref ref-type="bibr" rid="R26">26</xref>,<xref ref-type="bibr" rid="R27">27</xref></sup>. When tested <italic>in vivo</italic>, comparatively high daptomycin concentrations or prolonged incubation times were required to observe membrane depolarisation in <italic>B. subtilis</italic> and <italic>S. aureus</italic><sup><xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R28">28</xref></sup>, whilst no ion leakage was observed in <italic>B. subtilis</italic> at low yet growth inhibitory concentrations<sup><xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R20">20</xref></sup>. This is in clear contrast to other pore forming compounds that act rather rapidly<sup><xref ref-type="bibr" rid="R29">29</xref>,<xref ref-type="bibr" rid="R30">30</xref></sup>. Lastly, a delayed response to membrane permeability indicator dyes has been observed in daptomycin treated-<italic>B. subtilis</italic>, which was interpreted as the formation of large membrane pores<sup><xref ref-type="bibr" rid="R31">31</xref></sup>. However, <italic>B. subtilis</italic> undergoes extensive autolysis in response to conditions that compromise membrane integrity or cell wall synthesis including incubation with daptomycin<sup><xref ref-type="bibr" rid="R32">32</xref>–<xref ref-type="bibr" rid="R34">34</xref></sup>, thus complicating interpretation of the delayed membrane effects of daptomycin.</p><p id="P5">In this study, we observed that daptomycin indeed triggers extensive autolysis in the Gram-positive model organism <italic>B. subtilis</italic> under conditions that were previously linked to membrane pore formation. In <italic>B. subtilis</italic> strains deficient for key peptidoglycan-degrading enzymes required for induced autolysis, or in <italic>S. aureus</italic> that natively does not undergo autolysis in response to daptomycin, no significant membrane pore formation was observed. Thus, rather than representing daptomycin’s direct membrane activity, the delayed effects of daptomycin on <italic>B. subtilis</italic> membrane integrity are secondary, and caused by the cell’s autolytic processes. Using L-form cells lacking cell wall precursor lipids, we demonstrate here that daptomycin exhibits two distinct and independent mechanisms of action: (i) interaction with cell wall precursor lipids resulting in clustering of lipid II and associated fluid membrane microdomains and (ii) depolarisation of the cytoplasmic membrane that is independent of interactions with cell wall precursor lipids. At last, we show that rather than being due to direct daptomycin-membrane interaction, the large membrane domain clusters observed in <italic>B. subtilis</italic> in response to daptomycin are formed as part of the Lia-stress response and specifically require the IM30 protein LiaH<sup><xref ref-type="bibr" rid="R35">35</xref>–<xref ref-type="bibr" rid="R37">37</xref></sup>.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>Daptomycin induces autolysis without pore formation in <italic>B. subtilis</italic></title><p id="P6">To investigate whether daptomycin forms large pores in the cytoplasmic membrane of <italic>B. subtilis</italic> and the kinetics of the process, we performed time-resolved SYTOX Green membrane permeability assays using a fluorescence plate reader. SYTOX Green is a membrane impermeant DNA intercalating dye that can stain the bacterial nucleoid when cell entry is facilitated by pores formed within the cytoplasmic membrane<sup><xref ref-type="bibr" rid="R38">38</xref></sup>. Given the size of the SYTOX Green molecule (approx. 600 Da), a large pore size is needed for its passage. Indeed, the known pore forming lantibiotic nisin induced a rapid increase in SYTOX Green fluorescence (<xref ref-type="fig" rid="F1">Fig. 1a</xref>). Daptomycin treatment also increased SYTOX Green staining, however, consistent with previous studies using a similar permeability indicator dye propidium iodide<sup><xref ref-type="bibr" rid="R31">31</xref></sup>, this was found to be a slow process starting approximately 30 minutes following daptomycin addition. Due to this delay, and the ability of membrane-targeting compounds to induce autolysis in <italic>B. subtilis</italic><sup><xref ref-type="bibr" rid="R33">33</xref></sup>, we tested whether this apparent membrane permeation was due to autolysis or direct membrane pore formation. For this aim, the assay was repeated with a <italic>B. subtilis</italic> strain deficient for the major autolysins (<italic>ΔlytABCDEF).</italic> The minimum inhibitory concentration (MIC) of daptomycin was not affected by the absence of autolysins (1.6 μg/ml in wild type and <italic>ΔlytABCDEF</italic> cells), yet a clear suppression in daptomycin-induced SYTOX Green fluorescence was observed in this strain, indicating involvement of autolytic processes (<xref ref-type="fig" rid="F1">Fig. 1b</xref>). Similar suppression was not observed for nisin.</p><p id="P7">To observe this phenomenon on a single-cell level, phase contrast and SYTOX Green fluorescence microscopy was performed on <italic>B. subtilis</italic> wild type. Cells were treated with two concentrations of daptomycin (the minimum concentration to inhibit <italic>B. subtilis</italic> growth at an OD<sub>600</sub> of 0.3 [<xref ref-type="supplementary-material" rid="SD1">Fig. S1</xref>] and two-fold this), and at two time points (5 min and 25 min), to observe the early and late stages of its action. It became immediately apparent, especially at the later time point (25 min), that many of the cells had indeed lysed as indicated by the presence of phase light cells (white arrows; <xref ref-type="fig" rid="F1">Fig. 1c</xref>). In fact, when the proportion of phase light cells was quantified, irrespective of the used daptomycin concentration, approximately 30-40% of all cells had lysed by 25 minutes of treatment (<xref ref-type="fig" rid="F1">Fig. 1d</xref>). Importantly, the majority of the remaining phase dark cells were not stained by SYTOX Green, in contrast to cells incubated with nisin. We therefore hypothesised that, rather than large pore formation allowing SYTOX Green to enter the cell, the delayed SYTOX Green fluorescence observed in the plate reader data was due to staining of extracellular DNA released during autolysis. Indeed, lysis-derived extracellular DNA stained by SYTOX Green was frequently observed in cells incubated with daptomycin whilst nisin-treated cells consistently exhibited intracellular staining indicative of pore formation (<xref ref-type="fig" rid="F1">Fig. 1e</xref>). Finally, we validated that daptomycin was binding to cells by exploiting the fluorescence emission from its naturally fluorescent amino acid kynurenine<sup><xref ref-type="bibr" rid="R10">10</xref>,<xref ref-type="bibr" rid="R39">39</xref></sup> (<xref ref-type="fig" rid="F1">Fig. 1e</xref>). In conclusion, whilst daptomycin can bind <italic>B. subtilis</italic> cells and trigger positive SYTOX Green signals, these appear to be linked to cell autolysis rather than being indicative of pore formation.</p></sec><sec id="S4"><title>Daptomycin does not trigger pore formation even in the absence of autolysis</title><p id="P8">As the majority of cells were undergoing cell lysis at the later time points, we next investigated the action of daptomycin in cells lacking key cell wall-lytic enzymes and, thus, exhibiting supressed autolytic behaviour. For this aim, we performed phase contrast and SYTOX Green fluorescence microscopy of daptomycin-treated <italic>B. subtilis ΔlytABCDEF</italic>. Deletion of the major autolysins in <italic>B. subtilis</italic> results in a cell chaining phenotype linked to a defect in cell separation after division<sup><xref ref-type="bibr" rid="R40">40</xref></sup>. To distinguish individual cells within the chain, the cells were co-stained with the membrane dye FM 5-95 (<xref ref-type="fig" rid="F2">Fig. 2a</xref>). As expected, daptomycin-induced autolysis observed for the wild type cells was abolished in <italic>B. subtilis ΔlytABCDEF</italic> (<xref ref-type="fig" rid="F2">Fig. 2</xref>). Crucially, most cells remained free from SYTOX Green staining at both daptomycin concentrations and both time points, compared to ~100% of nisin-treated cells exhibiting a positive, intracellular SYTOX Green signal (<xref ref-type="fig" rid="F2">Fig. 2b</xref>). Again, we confirmed binding of the antibiotic to cells through detection of daptomycin’s intrinsic fluorescence (<xref ref-type="fig" rid="F2">Fig. 2c</xref>). Overall, this demonstrates that, even in the absence of autolysis that might obscure and overshadow other more direct activities, no large pore formation occurs in <italic>B. subtilis</italic> as a result of daptomycin treatment.</p></sec><sec id="S5"><title>Absence of pore formation upon daptomycin treatment is conserved in <italic>Staphylococcus aureus</italic></title><p id="P9">As daptomycin is commonly used against multidrug-resistant Gram-positive infections<sup><xref ref-type="bibr" rid="R1">1</xref></sup>, we decided to test whether this mode of action was also observed in the Gram-positive pathogen <italic>Staphylococcus aureus</italic>. In contrast to <italic>B. subtilis</italic>, treatment with daptomycin at a range of concentrations from 1 to 20 μg/ml did not trigger lysis in <italic>S. aureus</italic> wild type cells, even though growth was inhibited at concentrations above 10 μg/ml (<xref ref-type="supplementary-material" rid="SD1">Fig. S1</xref>). To follow daptomycin’s effect on membrane potential and integrity in <italic>S. aureus</italic>, we performed a combined DiSC3(5) and SYTOX Green fluorescence microscopy time course experiment of cells treated with 5 μg/ml and 10 μg/ml daptomycin, respectively. DiSC3(5) is a voltage-sensitive fluorescent dye which, due to its cationic and hydrophobic nature, accumulates in polarised cells and is released upon depolarisation<sup><xref ref-type="bibr" rid="R41">41</xref>,<xref ref-type="bibr" rid="R42">42</xref></sup>. Similarly to previous observations in <italic>B. subtilis</italic><sup><xref ref-type="bibr" rid="R20">20</xref></sup>, membrane depolarisation was gradual, heterogenous, and concentration-dependent (<xref ref-type="fig" rid="F3">Fig. 3a, b</xref>). Crucially, no membrane pore formation was observed even for cells that were substantially depolarised, with only a minor fraction of the cell population exhibiting positive SYTOX Green signals after an extended incubation time of 60 minutes (<xref ref-type="fig" rid="F3">Fig. 3a, b</xref>). This is in clear contrast to the positive control nisin which acts though pore formation and, thus, exhibits depolarisation that coincides with positive SYTOX Green signals (<xref ref-type="fig" rid="F3">Fig. 3a</xref>). Thus, the ability of daptomycin to trigger membrane depolarisation in a manner that does not rely on large pore formation is conserved between <italic>B. subtilis</italic> and <italic>S. aureus.</italic></p></sec><sec id="S6"><title>Daptomycin does not cluster fluid membrane microdomains in the absence of cell wall precursor lipids, but still triggers membrane depolarisation</title><p id="P10">It was previously shown by ourselves and collaborators that daptomycin interferes with fluid membrane microdomains in <italic>B. subtilis</italic>; hypothesised to be due to induced clustering of cell wall precursor lipids such as lipid II<sup><xref ref-type="bibr" rid="R20">20</xref></sup>. More recently, a direct interaction between daptomycin, undecaprenyl coupled peptidoglycan precursors and the anionic phospholipid PG was demonstrated by Grein <italic>et al</italic><sup><xref ref-type="bibr" rid="R22">22</xref></sup>; consistent with our hypothesis. We therefore aimed to investigate whether the fluid membrane microdomain clusters induced by daptomycin <italic>in vivo</italic> are indeed mediated by its interactions with cell wall precursor lipids. Since cell wall synthesis is essential for normal <italic>B. subtilis</italic> cells, we focused on L-forms, which are cell wall deficient bacterial variants<sup><xref ref-type="bibr" rid="R43">43</xref>,<xref ref-type="bibr" rid="R44">44</xref></sup>. <italic>B. subtilis</italic> can be converted to an L-form state either by deleting essential genes in the cell wall biosynthesis pathway, or by stimulating phospholipid synthesis in the presence of cell wall antibiotics<sup><xref ref-type="bibr" rid="R45">45</xref></sup>. To test the role of cell wall precursor lipids in the formation of fluid membrane microdomains, we deleted <italic>uppS</italic>, which encodes undecaprenyl pyrophosphate synthase, thereby eliminating the synthesis of any undecaprenyl-coupled cell wall precursors including lipid II. Perhaps surprisingly, daptomycin was equally growth inhibitory in both L-forms that maintain synthesis of cell wall precursor lipids but do not synthesise peptidoglycan, and L-forms that lack cell wall precursor lipids altogether (<xref ref-type="supplementary-material" rid="SD1">Fig. S2, S3</xref>). We then performed FM 5-95 fluorescence microscopy, which allows the visualisation of daptomycin-induced fluid membrane regions<sup><xref ref-type="bibr" rid="R20">20</xref></sup>, with both strains of <italic>B. subtilis</italic> L-forms. Whilst daptomycin retained the ability to induce fluid membrane domain clusters in L-forms producing cell wall precursor lipids, the cell membranes remained homogeneous in their absence (<xref ref-type="fig" rid="F4">Fig. 4a, b</xref>). The ability of daptomycin to induce lipid domains thus indeed relies on the presence of cell wall precursor lipids. Importantly, this phenomenon provides independent <italic>in vivo</italic> support for the interaction between daptomycin and cell wall precursor lipids.</p><p id="P11">We next wanted to determine whether daptomycin-induced membrane depolarisation was also dependent on its interaction with cell wall precursor lipids and the lipid domains associated with these complexes. Using the L-form strain lacking cell wall precursor lipids, we performed fluorescence microscopy of daptomycin-treated cells stained with DiSC3(5), with the channel forming peptide gramicidin as a positive control for membrane depolarisation<sup><xref ref-type="bibr" rid="R46">46</xref></sup>. As demonstrated by the microscopy images and quantification of single-cell fluorescence levels, the L-form cells exhibited DiSC3(5) staining indicative of membrane potential, whilst daptomycin retained its ability to induce membrane depolarisation in this strain (<xref ref-type="fig" rid="F4">Fig. 4c, d</xref>). This demonstrates that, unlike induction of lipid domains, the membrane depolarising activity of daptomycin is fully independent of its interaction with undecaprenyl-coupled cell wall precursors. Daptomycin, thus, exhibits two independent mechanisms of action: (i) lipid domain formation that relies upon specific interaction with cell wall precursor lipids, and (ii) membrane depolarisation triggered by interaction with regular membrane lipids.</p></sec><sec id="S7"><title>Large daptomycin-induced fluid membrane domains observed in <italic>B. subtilis</italic> depend on the IM30 homolog LiaH</title><p id="P12">Since daptomycin and other antibiotics that interfere with the lipid II biosynthesis cycle strongly induce the LiaRS two-component system<sup><xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R22">22</xref>,<xref ref-type="bibr" rid="R35">35</xref></sup>, we wanted to investigate whether daptomycin’s cell wall precursor interactions and the associated lipid domain formation are also modulated by the effector protein encoded by the <italic>lia</italic> regulon, LiaH. This possibility is further supported by the recent identification of LiaH as a member of the larger IM30/ESCRT-III membrane-remodelling superfamily<sup><xref ref-type="bibr" rid="R47">47</xref>–<xref ref-type="bibr" rid="R49">49</xref></sup>. For this aim, we performed fluorescence microscopy with the uncharged membrane fluorescent dye Nile Red, comparing wild type cells with cells deficient for LiaH. In both strains, Nile red stained the membranes of unstressed cells in a uniform manner. Upon incubation with daptomycin, brightly stained Nile Red foci emerged in wild type cells that co-localised with daptomycin clusters (<xref ref-type="fig" rid="F5">Fig. 5</xref>, <xref ref-type="supplementary-material" rid="SD1">S4, S5</xref>). In the absence of LiaH, however, these large domain clusters did not form, and instead daptomycin binding was concentrated on smaller, more frequent domains around the whole membrane, consistent with ongoing tripartite complex formation between daptomycin, lipid II and PG. In contrast to <italic>B. subtilis</italic>, <italic>S. aureus</italic> does not encode homologs of LiaH or IM30 proteins in general. In this organism, a minor degree of lipid domain formation was observed following an extended (30-60 min) treatment with low concentrations of daptomycin (<xref ref-type="fig" rid="F6">Fig. 6</xref>). The observed domains were, however, more subtle than the strong LiaH-dependent lipid domain clusters observed in <italic>B. subtilis</italic>, and potentially similar to domains observed <italic>in vitro</italic> upon binding to PG-containing liposomes<sup><xref ref-type="bibr" rid="R50">50</xref></sup>. Taken together, this implies that the <italic>B. subtilis</italic> IM30-homolog LiaH plays an intriguing role in clustering daptomycin-cell wall precursor lipid complexes. Further work is needed, and ongoing within our labs, to elucidate the interplay between daptomycin, cell wall precursor lipids and the IM30 protein LiaH.</p></sec></sec><sec id="S8" sec-type="discussion"><title>Discussion</title><p id="P13">The antibacterial mechanism of daptomycin has remained controversial due to disagreeing findings obtained from <italic>in vitro</italic> and <italic>in vivo</italic> experiments, and the difficulties of distinguishing primary effects from their secondary, more pleiotropic consequences <italic>in vivo</italic><sup><xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R7">7</xref>,<xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R22">22</xref>,<xref ref-type="bibr" rid="R23">23</xref>,<xref ref-type="bibr" rid="R26">26</xref>–<xref ref-type="bibr" rid="R28">28</xref>,<xref ref-type="bibr" rid="R31">31</xref></sup>. We hope this manuscript brings clarity to three aspects of daptomycin’s complex antibacterial mechanism of action (<xref ref-type="fig" rid="F7">Fig. 7</xref>). Firstly, by demonstrating daptomycin’s ability to depolarise bacterial membranes independently of cell wall precursor lipids, our findings reconciliate data obtained from <italic>in vitro</italic> model systems that argue for daptomycin-induced membrane conductivity for small cations<sup><xref ref-type="bibr" rid="R26">26</xref>,<xref ref-type="bibr" rid="R27">27</xref></sup> with the more recent discovery of cell wall precursor lipid interactions<sup><xref ref-type="bibr" rid="R22">22</xref>,<xref ref-type="bibr" rid="R23">23</xref></sup>. By showing that clustering of fluid membrane domains by daptomycin requires both cell wall precursor lipids and LiaH, this study also provides <italic>in vivo</italic> evidence for the interaction between daptomycin and cell wall precursor lipids, supporting the daptomycin binding data obtained <italic>in vitro</italic><sup><xref ref-type="bibr" rid="R22">22</xref></sup>. Lastly, our observation that delayed membrane permeabilisation is a secondary cellular effect linked to autolysis explains why daptomycin-induced conductivity for large fluorophores can be observed <italic>in vivo,</italic> whilst <italic>in vitro</italic> conductivity is limited to small cations only<sup><xref ref-type="bibr" rid="R26">26</xref>,<xref ref-type="bibr" rid="R27">27</xref></sup>.</p><p id="P14">The postulated dual mechanism of action for daptomycin is intriguing in the context of antimicrobial resistance (AMR). AMR towards daptomycin does develop, but it either employs species-specific mechanisms such as vesicle shedding combined with lack of phenol-soluble modulins in <italic>S. aureus</italic><sup><xref ref-type="bibr" rid="R51">51</xref></sup> or is slow and/or multifactorial as in case of <italic>B. subtilis<sup><xref ref-type="bibr" rid="R35">35</xref></sup></italic> and <italic>Enterococcus faecium</italic><sup><xref ref-type="bibr" rid="R52">52</xref></sup>. Furthermore, the ability to depolarise the membrane in a cell wall precursor-independent manner explains why defence mechanisms, such as the Bce modules that protect Gram-positive bacteria from antimicrobial peptides that target cell wall precursor lipids<sup><xref ref-type="bibr" rid="R53">53</xref>–<xref ref-type="bibr" rid="R55">55</xref></sup> are not sufficient to protect from daptomycin. The proposed dual mechanism of action, thus, provides a logical explanation for the difficulty to evolve high-level resistance towards daptomycin.</p><p id="P15">The recent prominent discoveries of teixobactin<sup><xref ref-type="bibr" rid="R56">56</xref></sup> and clovibactin<sup><xref ref-type="bibr" rid="R57">57</xref></sup>, which both represent peptide antibiotics that target bacterial cell wall precursor lipids, have rekindled interest in this class of membrane-targeting antibiotics. What makes them attractive in terms of antibiotic development is their low resistance development potential, ability to overcome the resistance mechanisms currently in circulation, and improved selectivity towards bacterial membranes. Whilst positive in terms of AMR, identification and detailed study of such lead compounds is difficult due to the essential nature of the cell wall precursor lipids, necessitating the use of specialised <italic>in vitro</italic> approaches available in only few laboratories worldwide. The approach presented here, utilising L-forms, in which cell wall precursor lipids are not essential, provides a new approach for identifying novel cell wall precursor-targeting antibiotics, and a promising route towards studying their detailed mechanism of action <italic>in vivo</italic>.</p></sec><sec id="S9" sec-type="methods"><title>Methods</title><sec id="S10"><title>Strains, media and growth conditions</title><p id="P16">Strains and genotypes are listed in <xref ref-type="table" rid="T1">Table 1</xref>. <italic>S. aureus</italic> and <italic>B. subtilis</italic> strains were aerobically grown at 37 °C in lysogeny broth (LB) (Miller) (10 g/l tryptone, 5 g/l yeast extract, 10 g/l NaCl) supplemented with 1.25 mM CaCl2, with the exception of <italic>B. subtilis</italic> L-forms which were grown at 30 °C in a specialised medium detailed below.</p></sec><sec id="S11"><title>Generation and growth inhibition of <italic>B. subtilis</italic> L-forms</title><p id="P17">For generation of <italic>B. subtilis</italic> L-forms, strains were grown in LB with any appropriate antibiotics or inducers to mid-logarithmic phase at 37 °C with shaking. Cells were then washed in fresh LB and resuspended in Nutrient Broth (NB) (Oxoid) (1 g/l ‘Lab-Lemco’ powder, 2 g/l yeast extract, 5 g/l peptone, 5 g/l NaCl) supplemented with MSM (20 mM maleic acid, 20 mM MgCl<sub>2</sub>, 0.5 M sucrose) and 2 mg/ml lysozyme for an hour with gentle shaking to convert rod-shaped cells to protoplasts. L-forms were then propagated by diluting the protoplasts in NB/MSM supplemented with penicillin G (200 μg/ml) and growing at 30 °C without shaking for 2–4 days. For growth inhibition experiments, L-forms were diluted to an OD<sub>600</sub> of 0.1 and left untreated or treated with 10 μg/ml daptomycin. Cultures were then incubated at 30 °C without shaking until visible growth was observed.</p></sec><sec id="S12"><title>Strain construction</title><p id="P18">To clone the <italic>ispA(D92E)</italic> mutation, four DNA fragments were amplified using specific primers: the first fragment was amplified from 168 gDNA using the primer pair oAK320 and oAK374. This fragment included the upstream region of <italic>ispA</italic>, along with the 3’ end of the <italic>xseA</italic> gene, while incorporating the <italic>ispA(D92E)</italic> mutation at the 3’ end. A second fragment was amplified from 168 gDNA using the primers oAK375 and oAK376. This fragment introduced the <italic>ispA(D92E)</italic> mutation at its 5’ end, and at the 3’ end, it contained a sequence complementary to the spectinomycin resistance marker. The third fragment was amplified using primers oAK377 and oAK378 to isolate the spectinomycin resistance marker from HS34 gDNA, while also adding a sequence complementary to the <italic>dxs</italic> gene at its 3’ end. The fourth fragment was amplified from 168 gDNA using primers oAK379 and oAK380, targeting the <italic>dxs</italic> gene. The linear PCR products were gel-purified and assembled into a single construct using NEBuilder HiFi DNA Assembly before transformation. To construct the Δ<italic>uppS</italic> deletion, three DNA fragments were amplified using specific primers. The first fragment was amplified from 168 gDNA using the primer pair oAK288 and oAK289. This fragment included the 3’ end of the <italic>frr</italic> gene and extended up to the region immediately preceding the <italic>uppS</italic> start codon. A second fragment was generated to introduce a kanamycin resistance cassette. This was amplified using primers oAK282 and oAK283, which added complementary sequences at both the 3’ and 5’ ends of the cassette for efficient recombination. The kanamycin resistance cassette was derived from <sup><xref ref-type="bibr" rid="R58">58</xref></sup>. The third fragment, containing the <italic>cdsA</italic> and <italic>dxR</italic> sequences, was amplified from 168 gDNA using primers oAK290 and oAK291. Each linear PCR product was gel-purified, and the fragments were assembled into a single construct using NEBuilder HiFi DNA Assembly before transformation. To construct the pLOSS-<italic>uppS</italic> plasmid, the <italic>uppS</italic> coding sequence was amplified from 168 gDNA using primer pair oAK227 and oAK396. Primer oAK227 introduced a ribosome binding site previously used for expressing msfGFP-MreB<sup><xref ref-type="bibr" rid="R59">59</xref></sup> directly upstream of the <italic>uppS</italic> start codon. Primer oAK396 adds a complementary sequence at the 3’ end for efficient cloning into the pLOSS vector. A second round of PCR was performed using primers oAK388 and oAK396 to introduce pLOSS-specific complementary sequences at the 5’ end of the amplified product, facilitating seamless insertion into the pLOSS vector. The pLOSS plasmid backbone was amplified separately using primers oAK387 and oAK386. After gel purification of all linear PCR products, the <italic>uppS</italic> gene fragment was assembled into the pLOSS plasmid using NEBuilder HiFi DNA Assembly before transformation. Ultimately, <italic>ispA(D92E), ΔuppS</italic> and pLOSS-<italic>uppS</italic> were combined, resulting in strain AK0197. To generate the strain AK092, <italic>B. subtilis</italic> 168 was transformed with genomic DNA from strains RM81 and YK1738. To generate the strain CD11, <italic>B. subtilis</italic> MDS23 (168 <italic>trp</italic>+) was transformed with genomic DNA from BKK33120 (<italic>liaH::kan),</italic> followed by removal of the resistance cassette as described in Koo et al<sup><xref ref-type="bibr" rid="R58">58</xref></sup>.</p></sec><sec id="S13"><title>Growth experiments</title><p id="P19">Overnight cultures were diluted to an OD<sub>600</sub> of 0.05 and transferred to a 96-well plate at a final volume of 100 μL per well. Cells were then incubated in a BMG CLARIOstar Plus plate reader under constant agitation. After an OD<sub>600</sub> of 0.3-0.4 was reached, antibiotics were added, and OD<sub>600</sub> measurements were recorded for up to 10 hours.</p></sec><sec id="S14"><title>Used antibiotic and dyes</title><p id="P20">Daptomycin was purchased from Abcam; nisin, gramicidin ABCD, and Nile red from Sigma-Aldrich; SYTOX Green, FM 5-95, BODIPY-FL vancomycin, and FM 4-64 from Thermo Fisher Scientific; and DiSC3(5) from Anaspec. Daptomycin, nisin, FM 5-95, and SYTOX Green were dissolved in sterile water. Gramicidin ABCD, Nile red, DiSC3(5), BODIPY-FL vancomycin, and FM 4-64 were dissolved in sterile DMSO.</p></sec><sec id="S15"><title>Minimum inhibitory concentration (MIC) assay</title><p id="P21">Overnight cultures were diluted 1:100 in appropriate growth medium and grown to mid-logarithmic phase. Cells were then diluted to give a final concentration of 5×10<sup>5</sup> cells per well in a prewarmed 96-well microtitre plate. This plate was prepared with an initial high concentration of the desired compound followed by a serial two-fold dilution. After addition of the cells, the plate was incubated at 37 °C for 16 h with shaking at 700 rpm. The MIC was defined as the lowest compound concentration able to inhibit visible bacteria growth.</p></sec><sec id="S16"><title>Fluorometric determination of membrane pore formation</title><p id="P22">Cultures were grown to logarithmic growth phase and, if needed, adjusted to an OD<sub>600</sub> of 0.5. SYTOX Green was then added to cells at a final concentration of 1 μM and cells were transferred to black polystyrene 96-well plates (Porvair Sciences). Fluorescence intensity was monitored until a stable baseline was obtained, followed by the addition of 10 μg/ml daptomycin. Measurements were taken every minute for 150 minutes using a BMG CLARIOstar multimode plate reader equipped with 485 nm (± 10) excitation, and 520 nm (± 10) emission filters. All media, plates, and instruments were warmed to 37 °C prior to use.</p></sec><sec id="S17"><title>Fluorescence microscopy</title><p id="P23">Samples (0.5 μl) were immobilised on Teflon-coated multi-spot microscope slides (Thermo Fisher) covered with a thin layer of 1.2% agarose (in H<sub>2</sub>O) and imaged immediately. Fluorescence microscopy of <italic>B. subtilis</italic> was performed using a Nikon Eclipse Ti equipped with a Nikon Plan Apo 100×/1.40 Oil Ph3 objective, CoolLED pE-4000 light source, Photometrics BSI sCMOS camera, and the filter sets: Chroma 49000 (EX350/50, DM400lp, EM460/50) used for daptomycin, Chroma 49002 (EX 470/40, DM495lpxr, EM 525/50) used for SYTOX Green and BODIPY FL-vancomycin, Chroma 49008 (EX560/40, DM585lprx, EM630/75) used for FM 5-95, and Nile red, and Semrock Cy5-4040C (EX 628/40, DM660lp, EM 692/40) used for DiSC<sub>3</sub>(5); while <italic>S. aureus</italic> samples were imaged using a Nikon Eclipse Ti2 equipped with a Photometrics PRIME BSI EXP camera, Lumencor Sola SE II FISH 365 light source and CFI Plan Apochromat DM Lambda 100X Oil objective (N.A. 1.45, W.D. 0.13mm). The filter used for DiSC3(5) was the same as above; whilst Semrock GFP-4050B was used for SYTOX Green, and Semrock NKBV-0014 for FM 4-64. All images were obtained using the Nikon NIS elements AR software version 5.42.02 and processed and analysed with Fiji<sup><xref ref-type="bibr" rid="R60">60</xref></sup>.</p><p id="P24">For fluorescence microscopy of <italic>B. subtilis</italic> L-forms, samples (70 μl) were transferred to a microscope slide containing a gene frame (1.7 cm X 2.8 cm; Thermo Fisher Scientific) and sealed with a plasma treated coverslip (20 mins plasma treatment in a plasma cleaner; Harrick Plasma). The sealed slide was then inverted and allowed to stand for 15 – 20 min to allow L-forms to settle and images were acquired using the microscope and camera setup stated above for <italic>B. subtilis</italic>. For fluorescent vancomycin staining, BODIPY-FL vancomycin was mixed one to one with unlabelled vancomycin and added to L-form cells at a final concentration of 1 μg/ml for 30 min. L-forms were then imaged as earlier described.</p></sec><sec id="S18"><title>Image analysis</title><p id="P25">Quantification of DiSC3(5) and SYTOX Green-fluorescence for individual cells was performed using Fiji<sup><xref ref-type="bibr" rid="R60">60</xref></sup>. In brief, any background fluorescence was first subtracted, originating from unincorporated dye and medium. For <italic>B. subtilis</italic>, individual cells were identified and converted to regions of interest (ROIs) by thresholding of corresponding phase contrast images. If cells adhered to each other or grew as chains, they were separated manually prior to automated cell detection. For S<italic>. aureus</italic>, segmentation was performed utilising the Weka segmentation plugin<sup><xref ref-type="bibr" rid="R61">61</xref></sup>. Cells that were not correctly detected by this tool were manually segmented, and out of focus cells were discarded from the analysis. Finally, mean fluorescence intensity values for individual cells across the population were obtained.</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Information</label><media xlink:href="EMS202416-supplement-Supplementary_Information.pdf" mimetype="application" mime-subtype="pdf" id="d56aAcEbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S19"><title>Acknowledgem ENTS</title><p>Funding for this research was provided by a Medical Research Council (MRC) DTP Studentships MR/N013840/1 (J.A.B) and MR/W006944/1 (J.W), UKRI Future Leaders Fellowship MR/W009587/1 (K.M), and Biotechnology and Biological Sciences Research Council (BBSRC) grants BB/S00257X/1 and BB/X003035/1 (H.S). We would like to thank James Grimshaw for technical assistance with image analysis, Martin Andersson (Chalmers University of Technology) for access to BSL-II facilities, Kenneth H. Seistrup and Lauren Elliott for preliminary experiments leading to this project, Chris Duringer for construction of strains, and Susanne Gebhard for providing feedback to the manuscript during its preparation.</p></ack><fn-group><fn id="FN1" fn-type="con"><p id="P26"><bold>Author Contributions</bold></p><p id="P27">J.A.B., A-B.S, A.K. and J.W. performed the experiments, J.A.B, A.K., K.M, M.W., and H.S. designed experiments and helped with data interpretation. H.S and M.W. conceived and supervised the project. J.A.B. and H.S wrote the manuscript, with help from A.K., M.W., A-B.S. and K.M.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baltz</surname><given-names>RH</given-names></name><name><surname>Miao</surname><given-names>V</given-names></name><name><surname>Wrigley</surname><given-names>SK</given-names></name></person-group><article-title>Natural products to drugs: daptomycin and related lipopeptide antibiotics</article-title><source>Nat Prod Rep</source><year>2005</year><volume>22</volume><fpage>717</fpage><lpage>741</lpage><pub-id pub-id-type="pmid">16311632</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karas</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Structure-activity relationships of daptomycin lipopeptides</article-title><source>J Med Chem</source><year>2020</year><volume>63</volume><fpage>13266</fpage><lpage>13290</lpage><pub-id pub-id-type="pmid">32687352</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname><given-names>DA</given-names></name><name><surname>Wenzel</surname><given-names>M</given-names></name></person-group><article-title>More Than a Pore: A current perspective on the <italic>in vivo</italic> mode of action of the lipopeptide antibiotic daptomycin</article-title><source>Antibiotics</source><year>2020</year><volume>9</volume><fpage>17</fpage><comment>2020, Vol. 9, Page 17</comment><pub-id pub-id-type="pmcid">PMC7168178</pub-id><pub-id pub-id-type="pmid">31947747</pub-id><pub-id pub-id-type="doi">10.3390/antibiotics9010017</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>SD</given-names></name><name><surname>Palmer</surname><given-names>M</given-names></name></person-group><article-title>The action mechanism of daptomycin</article-title><source>Bioorg Med Chem</source><year>2016</year><volume>24</volume><fpage>6253</fpage><lpage>6268</lpage><pub-id pub-id-type="pmid">27288182</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eliopoulos</surname><given-names>GM</given-names></name><etal/></person-group><article-title><italic>In vitro</italic> and <italic>in vivo</italic> activity of LY 146032, a new cyclic lipopeptide antibiotic</article-title><source>Antimicrob Agents Chemother</source><year>1986</year><volume>30</volume><fpage>532</fpage><lpage>535</lpage><pub-id pub-id-type="pmcid">PMC176475</pub-id><pub-id pub-id-type="pmid">3024560</pub-id><pub-id pub-id-type="doi">10.1128/aac.30.4.532</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debono</surname><given-names>M</given-names></name><etal/></person-group><article-title>A21978C, a complex of new acidic peptide antibiotics: Isolation, chemistry, and mass spectral structure elucidation</article-title><source>J Antibiot (Tokyo)</source><year>1987</year><volume>40</volume><fpage>761</fpage><lpage>777</lpage><pub-id pub-id-type="pmid">3610833</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>NE</given-names></name><name><surname>Hobbs</surname><given-names>JN</given-names></name><name><surname>Alborn</surname><given-names>WE</given-names></name></person-group><article-title>Inhibition of peptidoglycan biosynthesis in Gram-positive bacteria by LY146032</article-title><source>Antimicrob Agents Chemother</source><year>1987</year><volume>31</volume><fpage>1093</fpage><lpage>1099</lpage><pub-id pub-id-type="pmcid">PMC174877</pub-id><pub-id pub-id-type="pmid">2821889</pub-id><pub-id pub-id-type="doi">10.1128/aac.31.7.1093</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huber</surname><given-names>FM</given-names></name><name><surname>Pieper</surname><given-names>RL</given-names></name><name><surname>Tietz</surname><given-names>AJ</given-names></name></person-group><article-title>The formation of daptomycin by supplying decanoic acid to <italic>Streptomyces roseosporus</italic> cultures producing the antibiotic complex A21978C</article-title><source>J Biotechnol</source><year>1988</year><volume>7</volume><fpage>283</fpage><lpage>292</lpage></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ball</surname><given-names>LJ</given-names></name><name><surname>Goult</surname><given-names>CM</given-names></name><name><surname>Donarski</surname><given-names>JA</given-names></name><name><surname>Micklefield</surname><given-names>J</given-names></name><name><surname>Ramesh</surname><given-names>V</given-names></name></person-group><article-title>NMR structure determination and calcium binding effects of lipopeptide antibiotic daptomycin</article-title><source>Org Biomol Chem</source><year>2004</year><volume>2</volume><fpage>1872</fpage><lpage>1878</lpage><pub-id pub-id-type="pmid">15227539</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>D</given-names></name><name><surname>Rozek</surname><given-names>A</given-names></name><name><surname>Okon</surname><given-names>M</given-names></name><name><surname>Hancock</surname><given-names>REW</given-names></name></person-group><article-title>Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin</article-title><source>Chem Biol</source><year>2004</year><volume>11</volume><fpage>949</fpage><lpage>957</lpage><pub-id pub-id-type="pmid">15271353</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rotondi</surname><given-names>KS</given-names></name><name><surname>Gierasch</surname><given-names>LM</given-names></name></person-group><article-title>A well-defined amphipathic conformation for the calcium-free cyclic lipopeptide antibiotic, daptomycin, in aqueous solution</article-title><source>Biopolymers</source><year>2005</year><volume>80</volume><fpage>374</fpage><lpage>385</lpage><pub-id pub-id-type="pmid">15815985</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>WRP</given-names></name><name><surname>Baek</surname></name><name><surname>Bin</surname><given-names>S</given-names></name><name><surname>Jung</surname><given-names>D</given-names></name><name><surname>Hancock</surname><given-names>REW</given-names></name><name><surname>Straus</surname><given-names>SK</given-names></name></person-group><article-title>NMR structural studies of the antibiotic lipopeptide daptomycin in DHPC micelles</article-title><source>Biochim Biophys Acta</source><year>2007</year><volume>1768</volume><fpage>3116</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">17945184</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotsogianni</surname><given-names>I</given-names></name><name><surname>Wood</surname><given-names>TM</given-names></name><name><surname>Alexander</surname><given-names>FM</given-names></name><name><surname>Cochrane</surname><given-names>SA</given-names></name><name><surname>Martin</surname><given-names>NI</given-names></name></person-group><article-title>Binding Studies Reveal Phospholipid Specificity and Its Role in the Calcium-Dependent Mechanism of Action of Daptomycin</article-title><source>ACS Infect Dis</source><year>2021</year><volume>7</volume><fpage>2612</fpage><lpage>2619</lpage><pub-id pub-id-type="pmcid">PMC8438661</pub-id><pub-id pub-id-type="pmid">34406007</pub-id><pub-id pub-id-type="doi">10.1021/acsinfecdis.1c00316</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epand</surname><given-names>RF</given-names></name><name><surname>Savage</surname><given-names>PB</given-names></name><name><surname>Epand</surname><given-names>RM</given-names></name></person-group><article-title>Bacterial lipid composition and the antimicrobial efficacy of cationic steroid compounds (Ceragenins)</article-title><source>Biochim Biophys Acta</source><year>2007</year><volume>1768</volume><fpage>2500</fpage><lpage>2509</lpage><pub-id pub-id-type="pmid">17599802</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hachmann</surname><given-names>AB</given-names></name><etal/></person-group><article-title>Reduction in membrane phosphatidylglycerol content leads to daptomycin resistance in <italic>Bacillus subtilis</italic></article-title><source>Antimicrob Agents Chemother</source><year>2011</year><volume>55</volume><fpage>4326</fpage><lpage>4337</lpage><pub-id pub-id-type="pmcid">PMC3165287</pub-id><pub-id pub-id-type="pmid">21709092</pub-id><pub-id pub-id-type="doi">10.1128/AAC.01819-10</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tally</surname><given-names>FP</given-names></name><etal/></person-group><article-title>Daptomycin: a novel agent for Gram-positive infections</article-title><source>Expert Opin Investig Drugs</source><year>1999</year><volume>8</volume><fpage>1223</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">15992147</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Randall</surname><given-names>CP</given-names></name><name><surname>Mariner</surname><given-names>KR</given-names></name><name><surname>Chopra</surname><given-names>I</given-names></name><name><surname>O’Neill</surname><given-names>AJ</given-names></name></person-group><article-title>The target of daptomycin is absent from <italic>Escherichia coli</italic> and other Gram-negative pathogens</article-title><source>Antimicrob Agents Chemother</source><year>2013</year><volume>57</volume><fpage>637</fpage><lpage>639</lpage><pub-id pub-id-type="pmcid">PMC3535891</pub-id><pub-id pub-id-type="pmid">23114759</pub-id><pub-id pub-id-type="doi">10.1128/AAC.02005-12</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mengin-Lecreulx</surname><given-names>D</given-names></name><name><surname>Allen</surname><given-names>NE</given-names></name><name><surname>Hobbs</surname><given-names>JN</given-names></name><name><surname>van Heijenoort</surname><given-names>J</given-names></name></person-group><article-title>Inhibition of peptidoglycan biosynthesis in <italic>Bacillus megaterium</italic> by daptomycin</article-title><source>FEMS Microbiol Lett</source><year>1990</year><volume>57</volume><fpage>245</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">2170230</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="web"><collab>U.S. Food and Drug Administration</collab><source>Cubicin (Daptomycin) Injection Drug Approval Package</source><year>2003</year><comment><ext-link ext-link-type="uri" xlink:href="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-572_Cubicin.cfm">https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-572_Cubicin.cfm</ext-link></comment></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Müller</surname><given-names>A</given-names></name><etal/></person-group><article-title>Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains</article-title><source>Proceedings of the National Academy of Sciences</source><year>2016</year><volume>113</volume><fpage>E7077</fpage><lpage>E7086</lpage><pub-id pub-id-type="pmcid">PMC5111643</pub-id><pub-id pub-id-type="pmid">27791134</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1611173113</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>K</given-names></name><etal/></person-group><article-title>Essential <italic>Bacillus subtilis</italic> genes</article-title><source>Proc Natl Acad Sci U S A</source><year>2003</year><volume>100</volume><fpage>4678</fpage><lpage>4683</lpage><pub-id pub-id-type="pmcid">PMC153615</pub-id><pub-id pub-id-type="pmid">12682299</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0730515100</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grein</surname><given-names>F</given-names></name><etal/></person-group><article-title>Ca<sup>2+</sup>-daptomycin targets cell wall biosynthesis by forming a tripartite complex with undecaprenyl-coupled intermediates and membrane lipids</article-title><source>Nat Commun</source><year>2020</year><volume>11</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmcid">PMC7081307</pub-id><pub-id pub-id-type="pmid">32193379</pub-id><pub-id pub-id-type="doi">10.1038/s41467-020-15257-1</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>D</given-names></name><name><surname>Patra</surname><given-names>N</given-names></name></person-group><article-title>Elucidating daptomycin’s antibacterial efficacy: Insights into the tripartite complex with lipid II and phospholipids in bacterial septum membrane</article-title><source>Journal of Physical Chemistry B</source><year>2024</year><volume>128</volume><fpage>4414</fpage><lpage>4427</lpage><pub-id pub-id-type="pmid">38690887</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boaretti</surname><given-names>M</given-names></name><name><surname>Canepari</surname><given-names>P</given-names></name><name><surname>Lleò</surname><given-names>MDM</given-names></name><name><surname>Satta</surname><given-names>G</given-names></name></person-group><article-title>The activity of daptomycin on <italic>Enterococcus faecium</italic> protoplasts: Indirect evidence supporting a novel mode of action on lipoteichoic acid synthesis</article-title><source>J Antimicrobial Chemother</source><year>1993</year><volume>31</volume><fpage>227</fpage><lpage>235</lpage><pub-id pub-id-type="pmid">8385093</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>D</given-names></name><name><surname>Domínguez-Cuevas</surname><given-names>P</given-names></name><name><surname>Daniel</surname><given-names>RA</given-names></name><name><surname>Mascher</surname><given-names>T</given-names></name></person-group><article-title>Cell envelope stress response in cell wall-deficient L-forms of <italic>Bacillus subtilis</italic></article-title><source>Antimicrob Agents Chemother</source><year>2012</year><volume>56</volume><fpage>5907</fpage><lpage>5915</lpage><pub-id pub-id-type="pmcid">PMC3486569</pub-id><pub-id pub-id-type="pmid">22964256</pub-id><pub-id pub-id-type="doi">10.1128/AAC.00770-12</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Muraih</surname><given-names>JK</given-names></name><name><surname>MacCormick</surname><given-names>B</given-names></name><name><surname>Silverman</surname><given-names>J</given-names></name><name><surname>Palmer</surname><given-names>M</given-names></name></person-group><article-title>Daptomycin forms cation- and size-selective pores in model membranes</article-title><source>Biochimica et Biophysica Acta</source><year>2014</year><volume>1838</volume><fpage>2425</fpage><lpage>2430</lpage><pub-id pub-id-type="pmid">24857935</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Scoten</surname><given-names>K</given-names></name><name><surname>Straus</surname><given-names>SK</given-names></name></person-group><article-title>Daptomycin leakage is selective</article-title><source>ACS Infect Dis</source><year>2016</year><volume>2</volume><fpage>682</fpage><lpage>687</lpage><pub-id pub-id-type="pmid">27669740</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silverman</surname><given-names>JA</given-names></name><name><surname>Perlmutter</surname><given-names>NG</given-names></name><name><surname>Shapiro</surname><given-names>HM</given-names></name></person-group><article-title>Correlation of daptomycin bactericidal activity and membrane depolarization in <italic>Staphylococcus aureus</italic></article-title><source>Antimicrob Agents Chemother</source><year>2003</year><volume>47</volume><fpage>2538</fpage><lpage>2544</lpage><pub-id pub-id-type="pmcid">PMC166110</pub-id><pub-id pub-id-type="pmid">12878516</pub-id><pub-id pub-id-type="doi">10.1128/AAC.47.8.2538-2544.2003</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenzel</surname><given-names>M</given-names></name><etal/></person-group><article-title>Proteomic response of <italic>Bacillus subtilis</italic> to lantibiotics reflects differences in interaction with the cytoplasmic membrane</article-title><source>Antimicrob Agents Chemother</source><year>2012</year><volume>56</volume><fpage>5749</fpage><lpage>5757</lpage><pub-id pub-id-type="pmcid">PMC3486579</pub-id><pub-id pub-id-type="pmid">22926563</pub-id><pub-id pub-id-type="doi">10.1128/AAC.01380-12</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenzel</surname><given-names>M</given-names></name><etal/></person-group><article-title>The multifaceted antibacterial mechanisms of the pioneering peptide antibiotics tyrocidine and gramicidin S</article-title><source>mBio</source><year>2018</year><volume>9</volume><elocation-id>e00802-18</elocation-id><pub-id pub-id-type="pmcid">PMC6178620</pub-id><pub-id pub-id-type="pmid">30301848</pub-id><pub-id pub-id-type="doi">10.1128/mBio.00802-18</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seydlová</surname><given-names>G</given-names></name><name><surname>Sokol</surname><given-names>A</given-names></name><name><surname>Lišková</surname><given-names>P</given-names></name><name><surname>Konopásek</surname><given-names>I</given-names></name><name><surname>Fišer</surname><given-names>R</given-names></name></person-group><article-title>Daptomycin pore formation and stoichiometry depend on membrane potential of target membrane</article-title><source>Antimicrob Agents Chemother</source><year>2018</year><volume>63</volume><elocation-id>e01589-18</elocation-id><pub-id pub-id-type="pmcid">PMC6325215</pub-id><pub-id pub-id-type="pmid">30323037</pub-id><pub-id pub-id-type="doi">10.1128/AAC.01589-18</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lacriola</surname><given-names>CJ</given-names></name><name><surname>Falk</surname><given-names>SP</given-names></name><name><surname>Weisblum</surname><given-names>B</given-names></name></person-group><article-title>Screen for agents that induce autolysis in <italic>Bacillus subtilis</italic></article-title><source>Antimicrob Agents Chemother</source><year>2013</year><volume>57</volume><fpage>229</fpage><pub-id pub-id-type="pmcid">PMC3535944</pub-id><pub-id pub-id-type="pmid">23089762</pub-id><pub-id pub-id-type="doi">10.1128/AAC.00741-12</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falk</surname><given-names>SP</given-names></name><name><surname>Noah</surname><given-names>JW</given-names></name><name><surname>Weisblum</surname><given-names>B</given-names></name></person-group><article-title>Screen for inducers of autolysis in <italic>Bacillus subtilis</italic></article-title><source>Antimicrob Agents Chemother</source><year>2010</year><volume>54</volume><fpage>3723</fpage><lpage>3729</lpage><pub-id pub-id-type="pmcid">PMC2935000</pub-id><pub-id pub-id-type="pmid">20606070</pub-id><pub-id pub-id-type="doi">10.1128/AAC.01597-09</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jolliffe</surname><given-names>LK</given-names></name><name><surname>Doyle</surname><given-names>RJ</given-names></name><name><surname>Streips</surname><given-names>UN</given-names></name></person-group><article-title>The energized membrane and cellular autolysis in <italic>Bacillus subtilis</italic></article-title><source>Cell</source><year>1981</year><volume>25</volume><fpage>753</fpage><lpage>763</lpage><pub-id pub-id-type="pmid">6793239</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hachmann</surname><given-names>AB</given-names></name><name><surname>Angert</surname><given-names>ER</given-names></name><name><surname>Helmann</surname><given-names>JD</given-names></name></person-group><article-title>Genetic analysis of factors affecting susceptibility of <italic>Bacillus subtilis</italic> to daptomycin</article-title><source>Antimicrob Agents Chemother</source><year>2009</year><volume>53</volume><fpage>1598</fpage><lpage>1609</lpage><pub-id pub-id-type="pmcid">PMC2663116</pub-id><pub-id pub-id-type="pmid">19164152</pub-id><pub-id pub-id-type="doi">10.1128/AAC.01329-08</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mascher</surname><given-names>T</given-names></name><name><surname>Zimmer</surname><given-names>SL</given-names></name><name><surname>Smith</surname><given-names>TA</given-names></name><name><surname>Helmann</surname><given-names>JD</given-names></name></person-group><article-title>Antibiotic-inducible promoter regulated by the cell envelope stress-sensing two-component system LiaRS of <italic>Bacillus subtilis</italic></article-title><source>Antimicrob Agents Chemother</source><year>2004</year><volume>48</volume><fpage>2888</fpage><lpage>2896</lpage><pub-id pub-id-type="pmcid">PMC478541</pub-id><pub-id pub-id-type="pmid">15273097</pub-id><pub-id pub-id-type="doi">10.1128/AAC.48.8.2888-2896.2004</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domínguez-Escobar</surname><given-names>J</given-names></name><etal/></person-group><article-title>Subcellular localization, interactions and dynamics of the phage-shock protein-like Lia response in <italic>Bacillus subtilis</italic></article-title><source>Mol Microbiol</source><year>2014</year><volume>92</volume><fpage>716</fpage><lpage>732</lpage><pub-id pub-id-type="pmid">24666271</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roth</surname><given-names>BL</given-names></name><name><surname>Poot</surname><given-names>M</given-names></name><name><surname>Yue</surname><given-names>ST</given-names></name><name><surname>Millard</surname><given-names>PJ</given-names></name></person-group><article-title>Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain</article-title><source>Appl Environ Microbiol</source><year>1997</year><volume>63</volume><fpage>2421</fpage><lpage>2431</lpage><pub-id pub-id-type="pmcid">PMC168536</pub-id><pub-id pub-id-type="pmid">9172364</pub-id><pub-id pub-id-type="doi">10.1128/aem.63.6.2421-2431.1997</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lakey</surname><given-names>JH</given-names></name><name><surname>Ptak</surname><given-names>M</given-names></name></person-group><article-title>Fluorescence indicates a calcium-dependent interaction between the lipopeptide antibiotic LY146032 and phospholipid membranes</article-title><source>Biochemistry</source><year>1988</year><volume>27</volume><fpage>4639</fpage><lpage>4645</lpage><pub-id pub-id-type="pmid">2844233</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Guttenplan</surname><given-names>SB</given-names></name><name><surname>Blair</surname><given-names>KM</given-names></name><name><surname>Kearns</surname><given-names>DB</given-names></name></person-group><article-title>Role of the σD-dependent autolysins in <italic>Bacillus subtilis</italic> population heterogeneity</article-title><source>J Bacteriol</source><year>2009</year><volume>191</volume><elocation-id>5775</elocation-id><pub-id pub-id-type="pmcid">PMC2737971</pub-id><pub-id pub-id-type="pmid">19542270</pub-id><pub-id pub-id-type="doi">10.1128/JB.00521-09</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>te Winkel</surname><given-names>JD</given-names></name><name><surname>Gray</surname><given-names>DA</given-names></name><name><surname>Seistrup</surname><given-names>KH</given-names></name><name><surname>Hamoen</surname><given-names>LW</given-names></name><name><surname>Strahl</surname><given-names>H</given-names></name></person-group><article-title>Analysis of antimicrobial-triggered membrane depolarization using voltage sensitive dyes</article-title><source>Front Cell Dev Biol</source><year>2016</year><volume>4</volume><fpage>29</fpage><pub-id pub-id-type="pmcid">PMC4829611</pub-id><pub-id pub-id-type="pmid">27148531</pub-id><pub-id pub-id-type="doi">10.3389/fcell.2016.00029</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buttress</surname><given-names>JA</given-names></name><etal/></person-group><article-title>A guide for membrane potential measurements in Gram-negative bacteria using voltage-sensitive dyes</article-title><source>Microbiology</source><year>2022</year><volume>168</volume><pub-id pub-id-type="pmid">36165741</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Errington</surname><given-names>J</given-names></name></person-group><article-title>L-form bacteria, cell walls and the origins of life</article-title><source>Open Biol</source><year>2013</year><volume>3</volume><pub-id pub-id-type="pmcid">PMC3603455</pub-id><pub-id pub-id-type="pmid">23303308</pub-id><pub-id pub-id-type="doi">10.1098/rsob.120143</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leaver</surname><given-names>M</given-names></name><name><surname>Domínguez-Cuevas</surname><given-names>P</given-names></name><name><surname>Coxhead</surname><given-names>JM</given-names></name><name><surname>Daniel</surname><given-names>RA</given-names></name><name><surname>Errington</surname><given-names>J</given-names></name></person-group><article-title>Life without a wall or division machine in <italic>Bacillus subtilis</italic></article-title><source>Nature</source><year>2009</year><volume>457</volume><fpage>849</fpage><lpage>853</lpage><pub-id pub-id-type="pmid">19212404</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercier</surname><given-names>R</given-names></name><name><surname>Kawai</surname><given-names>Y</given-names></name><name><surname>Errington</surname><given-names>J</given-names></name></person-group><article-title>Excess membrane synthesis drives a primitive mode of cell proliferation</article-title><source>Cell</source><year>2013</year><volume>152</volume><fpage>997</fpage><lpage>1007</lpage><pub-id pub-id-type="pmid">23452849</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hladky</surname><given-names>SB</given-names></name><name><surname>Haydon</surname><given-names>DA</given-names></name></person-group><article-title>Ion transfer across lipid membranes in the presence of gramicidin A. I. Studies of the unit conductance channel</article-title><source>Biochim Biophys Acta</source><year>1972</year><volume>274</volume><fpage>294</fpage><lpage>312</lpage><pub-id pub-id-type="pmid">5048999</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>TK</given-names></name><etal/></person-group><article-title>Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity</article-title><source>Cell</source><year>2021</year><volume>184</volume><fpage>3643</fpage><lpage>3659</lpage><elocation-id>e23</elocation-id><pub-id pub-id-type="pmid">34166613</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Junglas</surname><given-names>B</given-names></name><etal/></person-group><article-title>PspA adopts an ESCRT-III-like fold and remodels bacterial membranes</article-title><source>Cell</source><year>2021</year><volume>184</volume><fpage>3674</fpage><lpage>3688</lpage><elocation-id>e18</elocation-id><pub-id pub-id-type="pmid">34166616</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily</article-title><source>Cell</source><year>2021</year><volume>184</volume><fpage>3660</fpage><lpage>3673</lpage><elocation-id>e18</elocation-id><pub-id pub-id-type="pmcid">PMC8281802</pub-id><pub-id pub-id-type="pmid">34166615</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2021.05.041</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreutzberger</surname><given-names>MA</given-names></name><name><surname>Pokorny</surname><given-names>A</given-names></name><name><surname>Almeida</surname><given-names>PF</given-names></name></person-group><article-title>Daptomycin-phosphatidylglycerol domains in lipid membranes</article-title><source>Langmuir</source><year>2017</year><volume>33</volume><fpage>13669</fpage><lpage>13679</lpage><pub-id pub-id-type="pmcid">PMC5710797</pub-id><pub-id pub-id-type="pmid">29130685</pub-id><pub-id pub-id-type="doi">10.1021/acs.langmuir.7b01841</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pader</surname><given-names>V</given-names></name><etal/></person-group><article-title><italic>Staphylococcus aureus</italic> inactivates daptomycin by releasing membrane phospholipids</article-title><source>Nat Microbiol</source><year>2016</year><volume>2</volume><pub-id pub-id-type="pmid">27775684</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>W</given-names></name><etal/></person-group><article-title>Acquisition of daptomycin resistance by <italic>Enterococcus faecium</italic> confers collateral sensitivity to glycopeptides</article-title><source>Front Microbiol</source><year>2022</year><volume>13</volume><pub-id pub-id-type="pmcid">PMC9041417</pub-id><pub-id pub-id-type="pmid">35495706</pub-id><pub-id pub-id-type="doi">10.3389/fmicb.2022.815600</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dintner</surname><given-names>S</given-names></name><etal/></person-group><article-title>Coevolution of ABC transporters and two-component regulatory systems as resistance modules against antimicrobial peptides in Firmicutes bacteria</article-title><source>J Bacteriol</source><year>2011</year><volume>193</volume><fpage>3851</fpage><lpage>3862</lpage><pub-id pub-id-type="pmcid">PMC3147537</pub-id><pub-id pub-id-type="pmid">21665979</pub-id><pub-id pub-id-type="doi">10.1128/JB.05175-11</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gebhard</surname><given-names>S</given-names></name><name><surname>Mascher</surname><given-names>T</given-names></name></person-group><article-title>Antimicrobial peptide sensing and detoxification modules: unravelling the regulatory circuitry of <italic>Staphylococcus aureus</italic></article-title><source>Mol Microbiol</source><year>2011</year><volume>81</volume><fpage>581</fpage><lpage>587</lpage><pub-id pub-id-type="pmid">21696467</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobras</surname><given-names>CM</given-names></name><etal/></person-group><article-title>BceAB-type antibiotic resistance transporters appear to act by target protection of cell wall synthesis</article-title><source>Antimicrob Agents Chemother</source><year>2020</year><volume>64</volume><pub-id pub-id-type="pmcid">PMC7038271</pub-id><pub-id pub-id-type="pmid">31871088</pub-id><pub-id pub-id-type="doi">10.1128/AAC.02241-19</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>LL</given-names></name><etal/></person-group><article-title>A new antibiotic kills pathogens without detectable resistance</article-title><source>Nature</source><year>2015</year><volume>517</volume><fpage>455</fpage><lpage>459</lpage><comment>2015 517:7535</comment><pub-id pub-id-type="pmcid">PMC7414797</pub-id><pub-id pub-id-type="pmid">25561178</pub-id><pub-id pub-id-type="doi">10.1038/nature14098</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shukla</surname><given-names>R</given-names></name><etal/></person-group><article-title>An antibiotic from an uncultured bacterium binds to an immutable target</article-title><source>Cell</source><year>2023</year><volume>186</volume><fpage>4059</fpage><lpage>4073</lpage><elocation-id>e27</elocation-id><pub-id pub-id-type="pmid">37611581</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koo</surname><given-names>BM</given-names></name><etal/></person-group><article-title>Construction and analysis of two genome-scale deletion libraries for <italic>Bacillus subtilis</italic></article-title><source>Cell Syst</source><year>2017</year><volume>4</volume><fpage>291</fpage><lpage>305</lpage><elocation-id>e7</elocation-id><pub-id pub-id-type="pmcid">PMC5400513</pub-id><pub-id pub-id-type="pmid">28189581</pub-id><pub-id pub-id-type="doi">10.1016/j.cels.2016.12.013</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strahl</surname><given-names>H</given-names></name><name><surname>Bürmann</surname><given-names>F</given-names></name><name><surname>Hamoen</surname><given-names>LW</given-names></name></person-group><article-title>The actin homologue MreB organizes the bacterial cell membrane</article-title><source>Nat Commun</source><year>2014</year><volume>5</volume><elocation-id>3442</elocation-id><pub-id pub-id-type="pmcid">PMC3955808</pub-id><pub-id pub-id-type="pmid">24603761</pub-id><pub-id pub-id-type="doi">10.1038/ncomms4442</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname><given-names>J</given-names></name><etal/></person-group><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nat Methods</source><year>2012</year><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="pmcid">PMC3855844</pub-id><pub-id pub-id-type="pmid">22743772</pub-id><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arganda-Carreras</surname><given-names>I</given-names></name><etal/></person-group><article-title>Trainable Weka Segmentation: a machine learning tool for microscopy pixel classification</article-title><source>Bioinformatics</source><year>2017</year><volume>33</volume><fpage>2424</fpage><lpage>2426</lpage><pub-id pub-id-type="pmid">28369169</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anagnostopoulos</surname><given-names>C</given-names></name><name><surname>Spizizen</surname><given-names>J</given-names></name></person-group><article-title>Requirements for transformation in <italic>Bacillus subtilis</italic></article-title><source>J Bacteriol</source><year>1960</year><volume>81</volume><fpage>741</fpage><lpage>746</lpage><pub-id pub-id-type="pmcid">PMC279084</pub-id><pub-id pub-id-type="pmid">16561900</pub-id><pub-id pub-id-type="doi">10.1128/jb.81.5.741-746.1961</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheinpflug</surname><given-names>K</given-names></name><etal/></person-group><article-title>Antimicrobial peptide cWFW kills by combining lipid phase separation with autolysis</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><elocation-id>44332</elocation-id><pub-id pub-id-type="pmcid">PMC5343580</pub-id><pub-id pub-id-type="pmid">28276520</pub-id><pub-id pub-id-type="doi">10.1038/srep44332</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horsburgh</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>δb modulates virulence determinant expression and stress resistance: Characterization of a functional <italic>rsbU</italic> strain derived from <italic>Staphylococcus aureus</italic> 8325-4</article-title><source>J Bacteriol</source><year>2002</year><volume>184</volume><fpage>5457</fpage><lpage>5467</lpage><pub-id pub-id-type="pmcid">PMC135357</pub-id><pub-id pub-id-type="pmid">12218034</pub-id><pub-id pub-id-type="doi">10.1128/JB.184.19.5457-5467.2002</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>Daptomycin induces lysis without significant membrane pore formation in <italic>B. subtilis</italic>.</title><p>The effect of 10 μg/ml daptomycin on the fluorescence intensity of 1 μM SYTOX Green in (a) <italic>B. subtilis</italic> wild type cells and (b) <italic>B. subtilis</italic> cells deficient for cell wall autolytic proteins, LytA-F, at an OD<sub>600</sub> of 0.5. The pore-forming lantibiotic nisin (10 μM) was used for positive control. The time point of antibiotic addition is indicated by an arrow. Data are represented as mean±SD (n=3). (c) Phase contrast microscopy images of <italic>B. subtilis</italic> wild type cells untreated or treated with 10 μg/ml daptomycin for 25 minutes. Fully lysed (phase light) cells are highlighted with white arrows. (d) <italic>B. subtilis</italic> wild type cells were stained with 200 nM SYTOX Green and treated with either 5 μg/ml or 10 μg/ml daptomycin for 5 and 25 minutes. Percentage of total cells phase light (lysed), phase dark/SYTOX positive (pore formation) or phase dark/SYTOX negative (membrane intact) are shown. SYTOX positive was defined as a fluorescence intensity of 5,000 a.u. or greater. 10 μM of the lantibiotic nisin was used as a positive control for pore formation. n=65-146. (e) Phase contrast and fluorescence overlay of <italic>B. subtilis</italic> wild type cells with SYTOX Green and daptomycin shown in cyan and magenta, respectively, and treated with either 10 μM nisin or 10 μg/ml daptomycin. Daptomycin fluorescence was detected based on kynurenine autofluorescence. Scale bar, 3 μm. Strains used: <italic>B. subtilis</italic> 168 (WT) and <italic>B. subtilis</italic> KS19 (<italic>ΔlytABCDEF).</italic></p></caption><graphic xlink:href="EMS202416-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Daptomycin does not trigger membrane pore formation even in the absence of autolysis.</title><p>(a) Fluorescence microscopy images of <italic>B. subtilis ΔlytABCDEF</italic> cells co-stained with 2 μg/ml FM 5-95 (shown in grey) and 200 nM SYTOX Green (shown in cyan), in the absence or presence of either 5 μg/ml or 10 μg/ml daptomycin for 5 and 25 minutes (only the later timepoint shown). (b) Quantification of the percentage of phase light (lysed), phase dark/SYTOX positive (pore formation) or phase dark/SYTOX negative cells (membrane intact) is shown. 10 μM of the lantibiotic nisin was used as a positive control for pore formation. n=66-127. (c) Phase contrast and fluorescence overlay of <italic>B. subtilis ΔlytABCDEF</italic> cells, with SYTOX Green and daptomycin shown in cyan and magenta, respectively, and treated with either 10 μM nisin or 10 μg/ml daptomycin. Daptomycin fluorescence was detected based on kynurenine autofluorescence. Scale bar, 3 μm. Strain used: <italic>B. subtilis</italic> KS19 (<italic>ΔlytABCDEF).</italic></p></caption><graphic xlink:href="EMS202416-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>Daptomycin induces a slow and incomplete membrane depolarisation in <italic>S. aureus</italic>, without membrane pore formation.</title><p>(a) Phase contrast and fluorescence microscopy images of <italic>S. aureus</italic> cells stained with 200 nM SYTOX Green and 150 nM DiSC3(5) and treated with 5 μg/ml or 10 μg/ml daptomycin for 10, 30 and 60 min. The pore forming lantibiotic nisin was used as a positive control for membrane pore formation and depolarisation. Scale bar, 2 μm. (b) Quantification of fluorescence for individual cells from the dataset shown in panel A (n=231-706). Median fluorescence intensity is indicated with a magenta line, together with P values of a one-way, unpaired ANOVA. **** represents p &lt; 0.0001, ns, not significant. Strain used: <italic>S. aureus</italic> SH1000 (wild type).</p></caption><graphic xlink:href="EMS202416-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>Daptomycin requires interaction with undecaprenyl-coupled cell wall precursors for fluid membrane domain clustering, but not for membrane depolarisation.</title><p>(a) Phase contrast and fluorescence microscopy images of <italic>B. subtilis</italic> L-forms able and unable to produce lipid II stained with the membrane dye FM 5-95 and treated with either 2 μg/ml or 4 μg/ml of daptomycin. (b) Quantification of the variance of FM 5-95 for individual cells from the dataset shown in panel (a) (n = 25). Magenta lines indicate the median, while the P values represent the result of a one-way, unpaired ANOVA. **** represents p &lt; 0.0001, ns, not significant. (c) Phase contrast and fluorescence microscopy of <italic>B. subtilis Δupps</italic> L-form cells stained with 1 μM DiSC3(5), in the absence and presence of 10 μg/ml daptomycin (25 min). The channel forming peptide gramicidin was used as a positive control for membrane depolarisation (10 μM, 5 min). Scale bar, 3 μm. (d) Quantification of DiSC3(5)-fluorescence for individual cells from the dataset shown in panel (a) (n=65-78 cells). Median fluorescence intensity is indicated with a magenta line, together with P values of a one-way, unpaired ANOVA. **** represents p &lt; 0.0001. Strains used: <italic>B. subtilis</italic> AK092 (L-forms able to produce lipid II), <italic>B. subtilis</italic> AK0197 (L-forms unable to produce lipid II).</p></caption><graphic xlink:href="EMS202416-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title>LiaH plays a role in forming fluid daptomycin-lipid clusters.</title><p>Phase contrast and fluorescence microscopy of <italic>B. subtilis</italic> wild type (WT) and <italic>ΔliaH</italic> cells stained with 1 μg/ml Nile red (shown in magenta) and treated with 4 μg/ml daptomycin (shown in cyan) for 60 min. Due to the intrinsic fluorescence of daptomycin, its localisation can be directly observed. Scale bar, 3 μm. Strains used: <italic>B. subtilis</italic> 168 (wild type) and CD11 (<italic>ΔliaH).</italic></p></caption><graphic xlink:href="EMS202416-f005"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><title>Daptomycin induces subtle fluid membrane domains in <italic>S. aureus</italic>.</title><p>Phase contrast (insert) and fluorescence microscopy images of <italic>S. aureus</italic> cells stained with 1 μg/ml FM 4-64 and treated with either 5 μg/ml or 10 μg/ml daptomycin. Scale bar, 2 μm. White arrows indicate daptomycin-induced fluid lipid clustering. Note, here the membrane dye FM 4-64 was used as it produced better staining in <italic>S. aureus</italic>. Strain used: <italic>S. aureus</italic> SH1000.</p></caption><graphic xlink:href="EMS202416-f006"/></fig><fig id="F7" position="float"><label>Figure 7</label><caption><title>Proposed model of daptomycin dual mechanisms of action.</title><p>(a) Peripheral cell wall synthetic proteins and the undecaprenyl-coupled peptidoglycan precursor lipid II localise to fluid microdomains under normal growth conditions. (b) Calcium-daptomycin oligomers (Ca<sup>2+-</sup>dap) form a tripartite complex with phosphatidylglycerol (PG) and lipid II or bind directly to anionic phospholipids such as PG. (c) Tripartite complex formation inhibits cell wall synthesis by steric hindrance and by inducing detachment of cell wall synthetic proteins. The direct (lipid II-independent) interaction between Ca<sup>2+</sup>-dap and anionic phospholipids triggers membrane depolarisation and associated autolysis.</p></caption><graphic xlink:href="EMS202416-f007"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><title>Strains used in this study</title></caption><table frame="box" rules="all"><thead><tr style="background-color:#BFBFBF"><th align="left" valign="middle">Strain name</th><th align="left" valign="middle">Genotype</th><th align="left" valign="middle">Reference</th></tr></thead><tbody><tr><td align="left" valign="middle"><italic>B. subtilis</italic> 168</td><td align="left" valign="middle"><italic>trpC2</italic></td><td align="left" valign="middle"><xref ref-type="bibr" rid="R62">62</xref></td></tr><tr><td align="left" valign="middle"><italic>B. subtilis</italic> KS19</td><td align="left" valign="middle"><italic>lytABC::neo lytD::tet lytE::cat lytF::spc</italic></td><td align="left" valign="middle"><xref ref-type="bibr" rid="R63">63</xref></td></tr><tr><td align="left" valign="middle"><italic>B. subtilis</italic> AK092</td><td align="left" valign="middle"><italic>ispA xscb:TmKm (kan) amyE::spc Pxyl-accdA</italic></td><td align="left" valign="middle">This work.</td></tr><tr><td align="left" valign="middle"><italic>B. subtilis</italic> AK0197</td><td align="left" valign="middle"><italic>ispA(D92E)::spc uppS::kan pLOSS (Pspac-uppS) (mls)</italic></td><td align="left" valign="middle">This work.</td></tr><tr><td align="left" valign="middle"><italic>B. subtilis</italic> BKK33120</td><td align="left" valign="middle"><italic>liaH::kan</italic></td><td align="left" valign="middle"><xref ref-type="bibr" rid="R58">58</xref></td></tr><tr><td align="left" valign="middle"><italic>B. subtilis</italic> CD11</td><td align="left" valign="middle"><italic>trp+ ΔliaH</italic></td><td align="left" valign="middle">This work.</td></tr><tr><td align="left" valign="middle"><italic>B. subtilis</italic> RM81</td><td align="left" valign="middle"><italic>ispA xscb:TmKm (kan)</italic></td><td align="left" valign="middle"><xref ref-type="bibr" rid="R45">45</xref></td></tr><tr><td align="left" valign="middle"><italic>B. subtilis</italic> YK1738</td><td align="left" valign="middle"><italic>amyE::spc Pxyl-accDA</italic></td><td align="left" valign="middle"><xref ref-type="bibr" rid="R45">45</xref></td></tr><tr><td align="left" valign="middle"><italic>B. subtilis</italic> HS34</td><td align="left" valign="middle"><italic>mreD:pMutin4 (mreD1-157) amyE::spc Pxyl-gfp-mreB</italic></td><td align="left" valign="middle"><xref ref-type="bibr" rid="R59">59</xref></td></tr><tr><td align="left" valign="middle"><italic>S. aureus</italic> SH1000</td><td align="left" valign="middle">8325-4 <italic>rsbU+</italic></td><td align="left" valign="middle"><xref ref-type="bibr" rid="R64">64</xref></td></tr></tbody></table></table-wrap><table-wrap id="T2" position="float" orientation="portrait"><label>Table 2</label><caption><title>Oligonucleotides</title></caption><table frame="box" rules="all"><thead><tr style="background-color:#BFBFBF"><th align="left" valign="middle">Oligonucleotide</th><th align="left" valign="middle">Sequence</th></tr></thead><tbody><tr><td align="left" valign="middle">oAK227</td><td align="left" valign="middle">GTAGAAAGGAGATTCCTAGGATGCTCAACATACTCAAAAATTGGAAG</td></tr><tr><td align="left" valign="middle">oAK282</td><td align="left" valign="middle">TACCGTTCGTATAGCATACATTATAC</td></tr><tr><td align="left" valign="middle">oAK283</td><td align="left" valign="middle">TCTACCGTTCGTATAATGTATGCTATAC</td></tr><tr><td align="left" valign="middle">oAK288</td><td align="left" valign="middle">AAGTTGCTGAACCGTACATAAGAAG</td></tr><tr><td align="left" valign="middle">oAK289</td><td align="left" valign="middle">GTATGCTATACGAACGGTAGAGATTCCTCCGTCACCC</td></tr><tr><td align="left" valign="middle">oAK29O</td><td align="left" valign="middle">ACATTATACGAACGGTAGATTTCAGCAGAGAGGCCGGAG</td></tr><tr><td align="left" valign="middle">oAK29l</td><td align="left" valign="middle">GTATCCAGATCACCGACAGAGAC</td></tr><tr><td align="left" valign="middle">oAK32O</td><td align="left" valign="middle">GAAGGATGGCGTGCTGACCTGTG</td></tr><tr><td align="left" valign="middle">oAK374</td><td align="left" valign="middle">CAAATCGTCTTCATCCATGCATGG</td></tr><tr><td align="left" valign="middle">oAK375</td><td align="left" valign="middle">CATGCATGGATGAAGACGATTTGC</td></tr><tr><td align="left" valign="middle">oAK376</td><td align="left" valign="middle">TTAGTGATCTCTTGCCGCAATTAAATC</td></tr><tr><td align="left" valign="middle">oAK377</td><td align="left" valign="middle">GCGGCAAGAGATCACTAAGCTCATCCATGTCGACTCTAG</td></tr><tr><td align="left" valign="middle">oAK378</td><td align="left" valign="middle">GCTTCAAATTAGGATCGTTCTAATTGAGAGAAGIIICIATAGAAIIIIIC</td></tr><tr><td align="left" valign="middle">oAK379</td><td align="left" valign="middle">AACGATCCTAATTTGAAGCGGC</td></tr><tr><td align="left" valign="middle">oAK380</td><td align="left" valign="middle">CGTATTGAAGATTCTCAATCAGCTC</td></tr><tr><td align="left" valign="middle">oAK386</td><td align="left" valign="middle">CCAGCTTGTTGATACACTAATGC</td></tr><tr><td align="left" valign="middle">oAK387</td><td align="left" valign="middle">TAATTGTGAGCGCTCACAATTC</td></tr><tr><td align="left" valign="middle">oAK388</td><td align="left" valign="middle">GAATTGTGAGCGCTCACAATTATAGAAAGGAGATTCCTAGGATG</td></tr><tr><td align="left" valign="middle">oAK396</td><td align="left" valign="middle">TAGTGTATCAACAAGCTGGCTAAATTCCGCCAAACCTCCGG</td></tr></tbody></table></table-wrap></floats-group></article>